Prostate Cancer - Results from #21820

Impact of Charlson comorbidity index varies by age in patients with prostate cancer treated by radical prostatectomy: A competing risk regression analysis - Abstract November 18, 2013

External validation of preoperative nomograms predicting biochemical recurrence after radical prostatectomy - Abstract November 18, 2013

Regional variation in quality of prostate cancer care - Abstract November 18, 2013

Psychological impact of prostate biopsy: Physical symptoms, anxiety, and depression - Abstract November 18, 2013

Robust plan optimization for electromagnetic transponder guided hypo-fractionated prostate treatment using volumetric modulated arc therapy - Abstract November 18, 2013

Cancer-associated bone disease - Abstract November 18, 2013

Algeta ASA: Xofigo® (radium Ra 223 dichloride) granted marketing authorization in the European Union November 15, 2013

Prognostic model predicting metastatic castration-resistant prostate cancer survival in men treated with second-line chemotherapy - Abstract November 15, 2013

Post-radical prostatectomy predictive factors for biochemical recurrence - Abstract November 15, 2013

Diagnosis and multimodal therapy for extragastrointestinal stromal tumor of the prostate: A case report - Abstract November 15, 2013

Complete regression of advanced prostate cancer for ten years: A case report and review of the literature - Abstract November 15, 2013

Quality of life and toxicity from passively scattered and spot-scanning proton beam therapy for localized prostate cancer - Abstract November 15, 2013

Neoadjuvant androgen deprivation therapy leads to immediate impairment of vitality/hormonal and sexual quality of life: Results of a multicenter prospective study - Abstract November 15, 2013

Racial differences in longitudinal changes in serum prostate-specific antigen levels: The Olmsted County Study and the Flint Men's Health Study - Abstract November 15, 2013

An assessment of PTV margin based on actual accumulated dose for prostate cancer radiotherapy - Abstract November 15, 2013

Enzalutamide for treatment of patients with metastatic castration-resistant prostate cancer who have previously received docetaxel: U.S. Food and Drug Administration Drug Approval Summary - Abstract November 15, 2013

Evaluation of safety and analgesic consumption in patients with advanced cancer treated with zoledronic acid - Abstract November 14, 2013

"N of 1" case reports in the era of whole-genome sequencing - Abstract November 14, 2013

Conservative management of post-radical prostatectomy incontinence - Abstract November 14, 2013

Toxicity and efficacy of three dose-fractionation regimens of intensity-modulated radiation therapy for localized prostate cancer - Abstract November 14, 2013

Page 1092 of 1436